Harrow Inc
Clinical trials sponsored by Harrow Inc, explained in plain language.
Harrow Inc
HROW
NASDAQ
A pharmaceutical company focused on ophthalmic products and compounding pharmacies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.